Akero Therapeutics (AKRO) PT Lowered to $56 at Canaccord Genuity
Tweet Send to a Friend
(Updated - May 13, 2024 6:29 AM EDT)
Canaccord Genuity analyst Edward Nash lowered the price target on Akero ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Canaccord Genuity analyst Edward Nash lowered the price target on Akero ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
